You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of BioMed. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, BioMed received 151 review reports, from 142 reviewers. This past year, we worked with reviewers from 44 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the BioMed family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Abeer Mostafa Abdalhamed | Luis Coelho |
Abraham Pouliakis | Luis Larrea |
Abraham Wall-Medrano | Mahdi Mahdipour |
Adli Ali | Marietta Kiss |
Ahmed Mohsen | Mohamed Abuzaid |
Aminoddin Haji | Mohammadreza Shalbafan |
Anisuzzaman Anisuzzaman | Monia Vagni |
Anna Malkova | Muhammad N. Zahid |
Burook Misganaw | Natalino Lourenço Neto |
Christos Kourek | Nicolò Fabbri |
Deepak Kulkarni | Nidhi Joshi |
Faisal Maqbool Zahid | Nina Novozhilova |
Felipe Bonfim Freitas | Paola L. Carvajal Monroy |
Florence Carrouel | Remington L. Nevin |
Ghulam Jilany Khan | Samreen Sadaf |
Hanvedes Daovisan | Sergey Kolomeichuk |
Hiroyuki Noda | Shuo Li |
Hoi Leong Xavier Wong | Siyamalan Manivannan |
Ina Manuela Schüler | Syed Mohsin |
Jasneth Mullings | Tomasz Marciniak |
Jayanta Mondal | Vivana Costa |
John A. St. Cyr | Wireen Leila Dator |
Jong-Woon Choi | Xinyu Ling |
Jyotir Chatterjee | Yuanzhang Zheng |
Kamil Nelke | Yu-Lung Hsu |
Keren Xu | Ziqi Meng |